tiprankstipranks
Trending News
More News >
SIGA Technologies Inc (SIGA)
NASDAQ:SIGA
US Market
Advertisement

SIGA Technologies (SIGA) Drug Pipeline

Compare
466 Followers
Drug Name
Condition
Stage
Status
Study Name
Trial Start Date
Article
Tpoxx
Smallpox
Phase III
Completed
Safety, Tolerability and Pharmacokinetics of TPOXX When Administered Orally for 28 Days
Jun 23, 2021
Tecovirimat, Smallpox And Mpox Vaccine
Smallpox
Phase II
Active Not Recruiting
Study to Assess the Safety and Immunogenicity of TPOXX® When Administered Orally for 28 Days With JYNNEOS
Jun 23, 2021
Tecovirimat, Sevelamer Carbonate Oral Tablet, Sucroferric Oxyhydroxide Chewable Tablet, Calcium Acetate Oral Tablet, Lanthanum Carbonate Chewable Tablet
Smallpox
Phase IV
Completed
Drug-drug Interaction Study of TPOXX When Co-administered With Phosphate Binders
May 11, 2020
Tpoxx
Smallpox
Phase IV
Completed
Safety, Tolerability and PK of TPOXX in Adults Weighing More Than 120 KG
May 06, 2020
Tecovirimat
Smallpox
Phase III
Completed
A Trial to Assess the Safety, Tolerability, and Pharmacokinetics of the Anti-Orthopoxvirus Compound Tecovirimat
Jun 01, 2015
St-246
Healthy
Phase I
Completed
Phase I, Escalating, Multiple-Dose, ST-246 Safety, Tolerability and Pharmacokinetics 21-Day Trial in Healthy Volunteers
Feb 02, 2007

FAQ

What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases:
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
    What is a clinical trial?
    A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
      What drugs does SIGA Technologies Inc (SIGA) have in its pipeline
      SIGA is currently developing the following drugs: Tpoxx, Tecovirimat, Smallpox And Mpox Vaccine, Tecovirimat, Sevelamer Carbonate Oral Tablet, Sucroferric Oxyhydroxide Chewable Tablet, Calcium Acetate Oral Tablet, Lanthanum Carbonate Chewable Tablet. These drug candidates are in various stages of clinical development as the company works toward FDA approval.
        What am I Missing?
        Make informed decisions based on Top Analysts' activity
        Know what industry insiders are buying
        Get actionable alerts from top Wall Street Analysts
        Find out before anyone else which stock is going to shoot up
        Get powerful stock screeners & detailed portfolio analysis